FeesSafety
Pluang+

NeuroPace stock drops 37% after cutting 2026 revenue forecast amid federal probe.

Market News
16 Nov 2026, 23:48 WIB
PRNewsWire
View Source
Bearish
NeuroPace stock drops 37% after cutting 2026 revenue forecast amid federal probe.

NeuroPace shares fell over 37% after the company lowered its full-year 2026 revenue guidance to $91-$92 million, down from a prior forecast of $99.5-$101.5 million given just one quarter earlier. The revenue decline was attributed to sales-force restructuring, disruptions at key customer accounts, and exiting a distribution business. A federal investigation is underway to determine if NeuroPace made misleading statements about its revenue outlook, potentially violating securities laws. Investors who suffered losses may be eligible to participate in legal actions through Levi & Korsinsky law firm.

NeuroPace investigation notice provides context for health sector market activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 17, 2026 04:12 WIB: out of 150 priced health-sector US stocks, 29 rose and 121 fell today. Notable movers include ABEO at USD 2.58 with a 1-day change of +6.61% and Pluang order activity showing 40% Sell / 60% Buy, TWST at USD 104.49 down 6.37% with 0% Sell / 100% Buy, and BFLY at USD 5.70 down 6.33%, with typical hold times ranging from 21 to 28 days on Pluang.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
3 hours ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
3 hours ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
4 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
5 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App